Logo
Home  |  About Us  |  Contact
Quick links

FeedbackPrintFont sizeFont SmallFont Big
Left menu top
About usUnderline
Left menu bottom
Inside content top
News

 
Back to Newsroom

26/03/2021
New Guideline for Consolidation or Maintenance ST - Epithelial ovary, fallopian tube, or primary peritoneal carcinoma
***Sent on behalf of Dr. Sarah Ferguson, Ontario Gynecologic Cancers Lead, Disease Pathway Management, Ontario Health (Cancer Care Ontario)***
 
On behalf of the Program in Evidence Based Care, the Disease Pathway Management program is pleased to announce that a new guideline, GL #4-18, Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma, is now available on Ontario Health (Cancer Care Ontario)’s website.
 
Who should use the guideline?
Clinicians involved in the treatment of patients with newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma who have received first-line therapy with cytoreductive surgery and neoadjuvant or adjuvant therapy, including:
• Gynecologic oncologists
• Medical oncologists
• Radiation oncologists
• Gynecologists
• Primary care providers
• Genetic counsellors
• Medical geneticists
• Pathologists
 
For questions about this guideline, please contact Ontario Health (Cancer Care Ontario)’s Program in Evidence-Based Care at ccopgi@mcmaster.ca.
 
Inside content bottom
Created by Blue Lemon Media
Copyright © 2012. Waterloo Wellington Regional Cancer Program. All Rights Reserved
Drop hover Drop hover bg Drop hover top Drop hover bottom drop bottom drop bg menu after menu before menu bg menu top menu after menu hover bg quick bg quick bottom